These past few days have been very happy ones for all of us at Navina. As you've likely heard, we've successfully completed a $55 million Series C funding round led by Goldman Sachs, bringing our total funding to $100 million. This investment is a profound validation of the vision and hard work that have defined our journey since Shay Perera and I founded Navina in 2018.
Navina's journey so far
When Shay and I embarked on this quest, we quickly got used to hearing a variation of the following: “Who are these two Israeli entrepreneurs who think they can fix the American healthcare system? They’ve never even been treated in it!”
The skeptics weren't entirely wrong—we hadn’t personally navigated the complexities of American healthcare as patients. But in retrospect, our outsider perspective proved invaluable. From the start, we’ve listened closely to clinicians—the individuals who navigate these complexities every day. And we didn’t just listen to them. Our team of in-house clinicians ensures that we’re crafting practical, impactful solutions genuinely tailored to their everyday challenges. Navina’s AI is truly built by clinicians, for clinicians.
It’s been a challenging journey. Healthcare, especially in America, is a notoriously tough field for startups. But our understanding of the problem we set out to solve has remained unchanged since day one. At no point were we tempted to pivot or compromise our vision. We have continued to believe that meaningful transformation begins at the point of care, where enhancing physician-patient interactions can fundamentally improve outcomes.
You can call this foresight or naivete—I’m comfortable with either. But the validation from Goldman Sachs—together with the daily validation of clinicians across the United States—affirms that this vision has served us incredibly well.
Why Goldman Sachs chose us—and why we chose them
Goldman Sachs isn't just any investor. They are one of the largest and most respected investment banks in the world, with over 150 years of experience shaping industries. Their deep expertise and meticulous due diligence led them to a conclusion that makes me incredibly proud: Navina has the potential to significantly transform healthcare for the better.
What exactly did Goldman Sachs see in us? They recognized our unique ability to deliver two outcomes simultaneously—outcomes that rarely coexist for startups tackling massive, complex problems. First, they saw how effectively our AI copilot improves physician experience by saving them time and delivering actionable insights at the point of care. Securing the trust of over 10,000 clinicians and care team members across 1,300 clinics serving over three million patients is no small feat. Second, they saw how our solution positively impacts outcomes, proving its value in both quality of care and financial performance, a combination that remains elusive in healthcare innovation.
Why did we choose Goldman Sachs? Beyond their global reputation and financial strength, Goldman Sachs brings unparalleled strategic value. For us, this is first and foremost an exciting opportunity to drive Navina’s growth with the support of world-class experts. We plan to fully leverage their extensive network, strategic insights, and market expertise to accelerate our impact and reach.
What this means for Navina's customers
So, what does this milestone mean for our existing and future customers? Quite simply, it means more. More innovation, more partnerships, more physicians and patients benefitting from what Navina has to offer.
We'll continue tackling pressing documentation and workflow challenges, ensuring clinicians spend less time on administrative tasks and more time on meaningful patient interactions. We'll advance our technology to unlock the potential for genuinely personalized and preventive medicine.
With Goldman Sachs behind us, we’ll accelerate the development of our proprietary AI, enhancing its ability to surface critical clinical insights that enable proactive and precise patient care. We will also work closely with payers to improve health outcomes across member populations, improving value-based outcomes by fostering stronger cooperation and coordination between providers and payers. Our goal remains the same: to make Navina the definitive source of unified patient data that improves efficiency and care quality across healthcare—from payers and providers to the most important stakeholder, the patient.
I see this funding round as a signal to our customers, partners, and the broader healthcare community that Navina is poised to play a defining role in the future of healthcare. It’s a statement that we’re on the right path and that our ambition—to transform every outpatient interaction into one that is empathic, personalized, and proactive—is more than achievable.
Thank you to our incredible team, our supportive customers, and our visionary investors, both new and longstanding, for making this all possible. Working with you all to improve the lives of patients and their physicians is truly a pleasure.
.avif)
.png)
